Hannah Joseph

{
  "main_header": {
    "sid": 10039941,
    "name": "Hannah Joseph",
    "stock_name": "Hannah Joseph",
    "full_name": "Hannah Joseph Hospital Ltd",
    "name_url": "stocks-analysis/hannah-joseph",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 0,
    "country_id": 34,
    "currency": "INR",
    "cmp": "73.53",
    "chg": -0.57,
    "chgp": "-0.77%",
    "dir": -1,
    "prev_price": "74.10",
    "mcapval": "168.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 544687,
    "symbol": "",
    "ind_name": "Hospital",
    "ind_code": 94,
    "indexname": "India SENSEX",
    "isin": "INE0JVH01012",
    "curr_date": "May 08",
    "curr_time": "",
    "bse_nse_vol": 50000,
    "exc_status": "Active",
    "traded_date": "May 08, 2026",
    "traded_date_str": "2026 05 08",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/hannah-joseph-10039941-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [],
    "total": 0,
    "sid": "10039941",
    "stock_news_url": "https://www.marketsmojo.com/news/hannah-joseph-hospital-10039941"
  },
  "announcements": [
    {
      "caption": "Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A",
      "datetime": "27-Apr-2026",
      "details": "<b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=1px><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> </tr> <tr><td>1</td><td>Name of Company</td><td>Hannah Joseph Hospital Ltd</td></tr> <tr><td>2</td><td>CIN NO.</td><td>L74999TN2011PLC082860</td></tr> <tr><td>3</td> <td>Outstanding borrowing of company as on 31st March / 31st December as applicable (in Rs cr)</td> <td>25.09</td></tr> <tr><td>4</td><td>Highest Credit Rating during the previous FY </td><td>Nil</td></tr> <tr><td>4a</td><td>Name of the Credit Rating Agency issuing the Credit Rating mentioned in (4)</td><td>Not Applicable</td></tr> <tr><td>5</td><td>Name of Stock Exchange# in which the fine shall be paid in case of shortfall in the required borrowing under the framework</td><td>BSE</td></tr> </table> <br/><br/> <div> <div style=float:left;> We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26 2018. No</div> <br/><br/><br/> <div style=float:left;> Name of the Company Secretary: CS Yuvaraj Saravanan <br/> Designation: Company Secretary and Compliance Officer <br/> EmailId: cs@hannahjosephhospital.com</div> <div style=float:left;margin-left:50px;> Name of the Chief Financial Officer: Daniel Dayanand Fenn <br/> Designation: Chief Financial Officer <br/> EmailId: cfo@hannahjosephhospital.com</div> </div> <div> <br/> Date: 27/04/2026<br/><br/> <b>Note:<b> In terms para of 3.2(ii) of the circular beginning F.Y 2022 in the event of shortfall in the mandatory borrowing through debt securities a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore an entity identified as LC shall provide in its initial disclosure for a financial year the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets. </div>",
      "source": "BSE"
    },
    {
      "caption": "Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011",
      "datetime": "22-Apr-2026",
      "details": "The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Capital Square Financial Services Pvt Ltd",
      "source": "BSE"
    },
    {
      "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
      "datetime": "09-Apr-2026",
      "details": "Submission of Certificate received from RTA for the Quarter ended 31.03.2026 pursuant to regulation 74(5) of the SEBI (Depositories and Participants) Regulations 2018",
      "source": "BSE"
    }
  ],
  "corporate_actions": []
}

News and Views

No Recent News for the Company

View All News